TESTiBANKiFORiBasiciandiClinicaliPharmacologyi1
5th Edition by Bertram G. Katzung
i i i i i i
Chaptersi1i-i66iComplete
, Pagei2iofi822
TableiofiContents
1.iIntroduction:iTheiNatureiofiDrugsi&iDrugiDevelopmenti&iRegulation
2.iDrugiReceptorsi&iPharmacodynamics
3.iPharmacokineticsi&iPharmacodynamics:iRationaliDosingi&itheiTimeiCourseiofiDrugiAction
4.iDrugiBiotransformation
5.iPharmacogenomics
6.iIntroductionitoiAutonomiciPharmacology
7.iCholinoceptor-Activatingi&iCholinesterase-InhibitingiDrugs
8.iCholinoceptor-BlockingiDrugs
9.iAdrenoceptoriAgonistsi&iSympathomimeticiDrugs
10.iAdrenoceptoriAntagonistiDrugs
11.iAntihypertensiveiAgents
12.iVasodilatorsi&itheiTreatmentiofiAnginaiPectoris
13.iDrugsiUsediiniHeartiFailure
14.iAgentsiUsediiniCardiaciArrhythmias
15.iDiureticiAgents
16.iHistamine,iSerotonin,i&itheiErgotiAlkaloids
17.iVasoactiveiPeptides
18.iTheiEicosanoids:iProstaglandins,iThromboxanes,iLeukotrienes,i&iRelatediCompounds
19.iNitriciOxide
20.iDrugsiUsediiniAsthma
21.iIntroductionitoitheiPharmacologyiofiCNSiDrugs
22.iSedative-HypnoticiDrugs
23.iTheiAlcohols
24.iAntiseizureiDrugs
25.iGeneraliAnesthetics
26.iLocaliAnesthetics
27.iSkeletaliMuscleiRelaxants
28.iPharmacologiciManagementiofiParkinsonismi&iOtheriMovementiDisorders
29.iAntipsychoticiAgentsi&iLithium
30.iAntidepressantiAgents
31.iOpioidiAgonistsi&iAntagonists
32.iDrugsiofiAbuse
33.iAgentsiUsediiniCytopenias;iHematopoieticiGrowthiFactors
34.iDrugsiUsediiniDisordersiofiCoagulation
35.iAgentsiUsediiniDyslipidemia
36.iNonsteroidaliAnti-InflammatoryiDrugs,iDisease-
ModifyingiAntirheumaticiDrugs,iNonopioidiAnalgesics,i&iDrugsiUsediiniGout
, Pagei3iofi822
37.iHypothalamici&iPituitaryiHormones
38.iThyroidi&iAntithyroidiDrugs
39.iAdrenocorticosteroidsi&iAdrenocorticaliAntagonists
40.iTheiGonadaliHormonesi&iInhibitors
41.iPancreaticiHormonesi&iAntidiabeticiDrugs
42.iAgentsiThatiAffectiBoneiMineraliHomeostasis
43.iBeta-Lactami&iOtheriCelliWall-i&iMembrane-ActiveiAntibiotics
44.iTetracyclines,iMacrolides,iClindamycin,iChloramphenicol,iStreptogramins,i&iOxazolidinones
45.iAminoglycosidesi&iSpectinomycin
46.iSulfonamides,iTrimethoprim,i&iQuinolones
47.iAntimycobacterialiDrugs
48.iAntifungaliAgents
49.iAntiviraliAgents
50.iMiscellaneousiAntimicrobialiAgents;iDisinfectants,iAntiseptics,i&iSterilants
51.iClinicaliUseiofiAntimicrobialiAgents
52.iAntiprotozoaliDrugs
53.iClinicaliPharmacologyiofitheiAntihelminthiciDrugs
54.iCanceriChemotherapy
55.iImmunopharmacology
56.iIntroductionitoiToxicology:iOccupationali&iEnvironmental
57.iHeavyiMetaliIntoxicationi&iChelators
58.iManagementiofitheiPoisonediPatient
59.iSpecialiAspectsiofiPerinatali&iPediatriciPharmacology
60.iSpecialiAspectsiofiGeriatriciPharmacology
61.iDermatologiciPharmacology
62.iDrugsiUsediinitheiTreatmentiofiGastrointestinaliDiseases
63.iTherapeutici&iToxiciPotentialiofiOver-the-CounteriAgents
64.iDietaryiSupplementsi&iHerbaliMedications
65.iRationaliPrescribingi&iPrescriptioniWriting
66.iImportantiDrugiInteractionsi&iTheiriMechanismsi
, Pagei4iofi822
Chapteri1.iIntroduction:iTheiNatureiofiDrugsi&iDrugiDevelopmenti&iRegulation
1.
Ainurseiworkingiiniradiologyiadministersiiodineitoiaipatientiwhoiisihavingia
icomputeditomographyi(CT)iscan.iTheinurseiworkingionitheioncologyiunitiad
ministersichemotherapyitoipatientsiwhoihaveicancer.iAtitheiPubliciHealthiDep
artment,iainurseiadministersiaimeasles-mumps-rubellai(MMR)ivaccineitoiai14-
month-
oldichildiasiairoutineiimmunization.iWhichibranchiofipharmacologyibestidescr
ibesitheiactionsiofiallithreei nurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
ANSWER: B
Feedback:
Pharmacologyiisitheistudyiofitheibiologicieffectsiofichemicals.iNursesiareiinvo
lvediwithiclinicalipharmacologyioripharmacotherapeutics,iwhichiisiaibranchiof
ipharmacologyithatidealsiwithitheiusesiofidrugsitoitreat,iprevent,iandidiagnosei
disease.iTheiradiologyinurseiisiadministeringiaidrugitoihelpidiagnoseiaidisease
.iTheioncologyinurseiisiadministeringiaidrugitoihelpitreatiaidisease.iPharmacoe
conomicsiincludesianyicostsiinvolvediinidrugi therapy.
Pharmacodynamicsiinvolvesihowiaidrugiaffectsitheibodyiandip
harmacokineticsiisihowitheibodyiactsionitheibody.
2.
Aiphysicianihasiorderediintramusculari(IM)iinjectionsiofimorphine,iainarco
tic,ieveryi4ihoursiasineedediforipainiiniaimotorivehicleiaccidentivictim.iTheinu
rseiisiawareithisidrugihasiaihighiabuseipotential.iUnderiwhaticategoryiwouldim
orphineibeiclassified?
A) ScheduleiI
B) ScheduleiII